David M. McIntosh

David McIntosh advises a wide range of companies, investors, and institutions in the life sciences industry in strategic transactions involving intellectual property and technology, with particular focus on strategic collaborations and licensing transactions, mergers and acquisitions, joint ventures, supply and distribution arrangements, and co-commercialization and marketing agreements. Recognized by Chambers, Law360, Best Lawyers, and other publications as a leading practitioner in his field, David provides practical, commercial advice that leverages his over 25 years of experience representing key players in the life sciences industry.

David’s clients are global and varied, ranging from private and public biotech companies, to global biopharmaceutical, medical device, and diagnostic companies, to world-renowned academic institutions and international investment firms. David has developed a particular expertise in cross-border strategic transactions involving clients and counterparties in Europe, China, Japan, Korea, and the Middle East. David also advises clients regarding the use of artificial intelligence (AI) technologies in the life sciences industry, including clients that employ their own proprietary AI platforms and those that partner with AI providers. Although David’s practice focuses on the life sciences industry, he also has extensive experience advising companies and investors in the AI, technology and branded product industries with respect to strategic transactions involving intellectual property as well as day-to-day commercial and corporate matters.